ArticleFrontiers in immunology2022

Enhanced Therapeutic Efficacy of Combining Losartan and Chemo-Immunotherapy for Triple Negative Breast Cancer.

Qing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.